🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Millions of people each year sustain injuries, have tumors surg...
Status
Recruiting
Location
Johns Hopkins University School of Medicine
Start Date
2011-07-21
Trial ID
NCT01459107
This trial is a prospective, multi-center, randomized comparison study of 2...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04
Trial ID
NCT03834909
Treatments Being Tested
To compare between efficacy of phosphodiesterase5 inhibitors (tadalafil 5 m...
Status
Unknown
Location
Multiple Locations
Start Date
2022-05-01
Trial ID
NCT05236634
The study will evaluate the pharmacokinetics (PK) of AZD6793 when administe...
Status
Completed
Location
Research Site
Start Date
2024-07-23
Trial ID
NCT06494644
Treatments Being Tested
This is a phase 2, multicenter, single-arm study with a safety lead-in to i...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2022-06-02
Trial ID
NCT05195632
Treatments Being Tested
This is a single centre, proof-of-concept phase I trial of atezolizumab in ...
Status
Active Not Recruiting
Location
Royal Marsden Hospital NHS Foundation Trust
Start Date
2018-08-13
Trial ID
NCT03673787
Treatments Being Tested
The primary objectives of this study are to evaluate the efficacy, safety, ...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-23
Trial ID
NCT02346721
Treatments Being Tested
Multicenter, prospective, open-labeled, 2-arm, non-comparative randomized p...
Status
Completed
Location
Institut Bergonié
Start Date
2022-02-09
Trial ID
NCT04807816
Treatments Being Tested
The purpose of this study is to assess how well laroprovstat and ezetimibe ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2026-06-10
Trial ID
NCT07622433
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested